Programming cancer cells for high expression levels of Mcl1

EMBO Reports

Volumn 14, Issue 4, 2013, Pages 328-336

  Ertel, Franziska ^a   Nguyen, Mai ^a   Roulston, Anne ^a   Shore, Gordon C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

apoptosis; Bcl2; caspase; mitochondria; proteasome

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ANTINEOPLASTIC AGENT; NAVITOCLAX; OBATOCLAX; PROTEASOME; PROTEIN BCL 2; PROTEIN MCL 1; SABUTOCLAX; UBIQUITIN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; GENOME; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; APOPTOSIS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84876475662     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/embor.2013.20     Document Type: Review

References (100)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674
2. Yip KW, Reed JC (2008) Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406
3. Beroukhim R et al (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905
4. Wei G et al (2012) Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency. Cancer Cell 21: 547-562
5. Thomas LW, Lam C, Edwards SW (2010) Mcl-1; the molecular regulation of protein function. FEBS Lett 584: 2981-2989
6. Craig RW (2002) MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16: 444-454 (Pubitemid 34449724)
7. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993) MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 90: 3516-3520 (Pubitemid 23111397)
8. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC (1995) Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146: 1309-1319
9. Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ (2000) Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 14: 23-27 (Pubitemid 30051575)
10. Dzhagalov I, St John A, He YW (2007) The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 109: 1620-1626 (Pubitemid 46239596)
11. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ (2003) Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426: 671-676 (Pubitemid 38009376)
12. Opferman JT, Iwasaki H, Ong CC, Suh H, Mizuno S, Akashi K, Korsmeyer SJ (2005) Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 307: 1101-1104 (Pubitemid 40262114)
13. Arbour N et al (2008) Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage. J Neurosci 28: 6068-6078
14. Vick B et al (2009) Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology 49: 627-636
15. Peperzak V et al (2013) Mcl-1 is essential for the survival of plasma cells. Nat Immunol 14: 290-297
16. Debrincat MA et al (2012) Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival. Blood 119: 5850-5858
17. Kodama T et al (2012) Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages. Cell Death Differ 19: 1856-1869
18. Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, Metcalf D, Scott CL, Cory S (2010) Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance. Blood 116: 3197-3207
19. Zhou P, Levy NB, Xie H, Qian L, Lee CY, Gascoyne RD, Craig RW (2001) MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 97: 3902-3909
20. Zhou P, Qian L, Bieszczad CK, Noelle R, Binder M, Levy NB, Craig RW (1998) Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage. Blood 92: 3226-3239 (Pubitemid 28492330)
21. Glaser SP et al (2012) Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev 26: 120-125
22. Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT, Tomasson MH (2010) Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia. J Clin Invest 120: 2109-2118
23. Allen TD, Zhu CQ, Jone KD, Yanagawa N, Tsao MS, Bishop JM (2011) Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer. Cancer Res 71: 2212-2221
24. Awan FT et al (2009) Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. Blood 113: 535-537
25. Kaufmann SH, Karp JE, Svingen PA, Krajewski S, Burke PJ, Gore SD, Reed JC (1998) Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood 91: 991-1000 (Pubitemid 28078303)
26. Warr MR, Shore GC (2008) Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 8: 138-147 (Pubitemid 351516833)
27. Happo L, Strasser A, Cory S (2012) BH3-only proteins in apoptosis at a glance. J Cell Sci 125: 1081-1087
28. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619 (Pubitemid 23259742)
29. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116: 205-219 (Pubitemid 38167313)
30. Chen L et al (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403 (Pubitemid 40193310)
31. Heath-Engel HM, Chang NC, Shore GC (2008) The endoplasmic reticulum in apoptosis and autophagy: role of the BCL-2 protein family. Oncogene 27: 6419-6433
32. Martinou JC, Youle RJ (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 21: 92-101
33. Shamas-Din, Brahmbhatt H, Leber B, Andrews DW (2011) BH3-only proteins: orchestrators of apoptosis. Biochim Biophys Acta 1813: 508-520
34. Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621-632
35. Gavathiotis E, Reyna DE, Davis ML, Bird GH, Walensky LD (2010) BH3-triggered structural reorganization drives the activation of proapoptotic BAX. Mol Cell 40: 481-492
36. Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH (2006) Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 8: 1348-1358 (Pubitemid 44835109)
37. Kushnareva Y, Andreyev AY, Kuwana T, Newmeyer DD (2012) Bax activation initiates the assembly of a multimeric catalyst that facilitates Bax pore formation in mitochondrial outer membranes. PLoS Biol 10: e1001394
38. Llambi F, Moldoveanu T, Tait SW, Bouchier-Hayes L, Temirov J, McCormick LL, Dillon CP, Green DR (2011) A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell 44: 517-531
39. Lovell JF, Billen LP, Bindner S, Shamas-Din A, Fradin C, Leber B, Andrews DW (2008) Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135: 1074-1084
40. Dewson G, Kratina T, Czabotar P, Day CL, Adams JM, Kluck RM (2009) Bak activation for apoptosis involves oligomerization of dimers via their α6 helices. Mol Cell 36: 696-703
41. Bogner C, Leber B, Andrews DW (2010) Apoptosis: embedded in membranes. Curr Opin Cell Biol 22: 845-851
42. Edlich F, Banerjee S, Suzuki M, Cleland MM, Arnoult D, Wang C, Neutzer A, Tiandra N, Youle RJ (2011) Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell 145: 104-116
43. Merino D et al (2009) The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins. J Cell Biol 186: 355-362
44. Montessuit S et al (2010) Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 142: 889-901
45. Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid LM, Green DR (2012) Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148: 988-1000
46. Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, Fairlie WD, Hinds MG, Colman PM (2007) Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 104: 6217-6222 (Pubitemid 47186075)
47. Dutta S et al (2010) Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. J Mol Biol 398: 747-762
48. Warr MR et al (2011) Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site. J Biol Chem 286: 25098-25107
49. Ross K, Rudel T, Kozjak-Pavlovic V (2009) TOM-independent complex formation of Bax and Bak in mammalian mitochondria during TNFα-induced apoptosis. Cell Death Differ 16: 697-707
50. Chou CH, Lee RS, Yang-Yen HF (2006) An internal EELD domain facilitates mitochondrial targeting of Mcl-1 via a Tom70-dependent pathway. Mol Biol Cell 17: 3952-3963
51. Ruffolo SC, Shore GC (2003) BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J Biol Chem 278: 25039-25045 (Pubitemid 37548667)
52. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14: 2060-2071 (Pubitemid 30637355)
53. Malin S, McManus S, Cobaleda C, Novatchkova M, Deloqu A, Bouillet P, Strasser A, Busslinger M (2010) Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 11: 171-179
54. Mérino D, Strasser A, Bouillet P (2012) Bim must be able to engage all pro-survival Bcl-2 family members for efficient tumor suppression. Oncogene 31: 3392-3396
55. Beverly LJ, Varmus HE (2009) MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family. Oncogene 28: 1274-1279
56. Konopleva M et al (2006) Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10: 375-388 (Pubitemid 44693472)
57. van Delft MF et al (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 10: 389-399
58. Germain M, Nguyen AP, Le Grand JN, Arbour N, Vanderluit JL, Park DS, Opferman JT, Slack RS (2011) MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner. EMBO J 30: 395-407
59. De Biasio A et al (2007) N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells. J Biol Chem 282: 23919-23936 (Pubitemid 47328002)
60. Huang CR, Yang-Yen HF (2010) The fast-mobility isoform of mouse Mcl-1 is a mitochondrial matrix-localized protein with attenuated anti-apoptotic activity. FEBS Lett 584: 3323-3330
61. Perciavalle RM et al (2012) Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol 14: 575-583
62. Matsuda N et al (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189: 211-221
63. Warr MR, Acoca S, Liu Z, Germain M, Watson M, Blanchette M, Wing SS, Shore GC (2005) BH3-ligand regulates access of MCL-1 to its E3 ligase. FEBS Lett 579: 5603-5608 (Pubitemid 41455637)
64. Zhong Q, Gao W, Du F, Wang X (2005) Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121: 1085-1095 (Pubitemid 40884398)
65. Hao Z et al (2012) The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J Exp Med 209: 173-186
66. Inuzuka H et al (2011) SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 471: 104-109
67. Wertz IE et al (2011) Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471: 110-114
68. Min SH et al (2012) Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol Cell 46: 771-783
69. Ding Q et al (2007) Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Mol Cell Biol 27: 4006-4017 (Pubitemid 47010998)
70. Dehan E et al (2009) betaTrCP-and Rsk1/2-mediated degradation of BimEL inhibits apoptosis. Mol Cell 33: 109-116
71. Vucic D, Dixit VM, Wertz IE (2011) Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat Rev Mol Cell Biol 12: 439-452
72. Harley ME, Allan LA, Sanderson HS, Clarke PR (2010) Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J 29: 2407-2420
73. Millman SE, Pagano M (2011) MCL1 meets its end during mitotic arrest. EMBO Rep 12: 384-385
74. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR (2006) Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 21: 749-760 (Pubitemid 43376126)
75. Morel C, Carlson SM, White FM, Davis RJ (2009) Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol Cell Biol 29: 3845-3852
76. Nifoussi SK, Vrana JA, Domina AM, De Biasio A, Gui J, Gregory MA, Hann SR, Craig RW (2012) Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer. PLoS ONE 7: e47060
77. Schwickart M et al (2010) Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463: 103-107
78. Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR (2010) A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med 16: 671-677
79. Allen JC, Talab F, Zuzel M, Lin K, Slupsky JR (2011) c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells. Blood 117: 2414-2422
80. Croxton R, Ma Y, Song L, Haura EB, Cress WD (2002) Direct repression of the Mcl-1 promoter by E2F1. Oncogene 21: 1359-1369 (Pubitemid 34214501)
81. Engelmann D, Pützer BM (2012) The dark side of E2F1: in transit beyond apoptosis. Cancer Res 72: 571-575
82. Moore MJ, Wang Q, Kennedy CJ, Silver PA (2010) An alternative splicing network links cell-cycle control to apoptosis. Cell 142: 625-636
83. Lindqvist L, Pelletier J (2009) Inhibitors of translation initiation as cancer therapeutics. Future Med Chem 1: 1709-1722
84. Mills JR et al (2008) mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sci USA 105: 10853-10858
85. Mott JL et al (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133-6140 (Pubitemid 47414372)
86. Garzon R et al (2009) MicroRNA 29b functions in acute myeloid leukemia. Blood 114: 5331-5341
87. Desjobert C et al (2011) MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 117: 6627-6637
88. Gong J, Zhang JP, Li B, Zeng C, You K, Chen MX, Yuan Y, Zhuang SM (2012) MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene [Epub ahead of print] doi:10.1038/onc.2012.318
89. Farh KK, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821 (Pubitemid 41814382)
90. Lam LT, Lu X, Zhang H, Lesniewski R, Rosenberg S, Semizarov D (2010) A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax). Mol Cancer Ther 9: 2943-2950
91. Thomas S et al (2012) Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther Targets 17: 61-75
92. Aranovich A, Liu Q, Collins T, Geng F, Dixit S, Leber B, Andrews DW (2012) Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Mol Cell 45: 754-763
93. Bodet L et al (2011) ABT-737 is highly effective against molecular subgroups of multiple myeloma. Blood 118: 3901-3910
94. Nguyen M et al (2007) Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. Proc Natl Acad Sci USA 104: 19512-19517
95. Cohen NA, Stewart ML, Gavathiotis E, Tepper JL, Bruekner SR, Koss B, Opferman JT, Walensky LD (2012) A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival. Chem Biol 19: 1175-1186
96. Kobayashi S et al (2007) Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem 282: 18407-18417 (Pubitemid 47100259)
97. Ding Q et al (2008) Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 68: 6109-6117
98. Kodama Y et al (2009) Antiapoptotic effect of c-Jun N-terminal kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis. Gastroenterology 136: 1423-1434
99. Inoshita S, Takeda K, Hatai T, Terada Y, Sano M, Hata J, Umezawa A, Ichijo H (2002) Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J Biol Chem 277: 43730-43734 (Pubitemid 36157790)
100. Domina AM, Vrana JA, Gregory MA, Hann SR, Craig RW (2004) MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 23: 5301-5315 (Pubitemid 39005806)